Marc van Dijk
2023
In 2023, Marc van Dijk earned a total compensation of $524.8K as Chief Scientific Officer at MiNK Therapeutics, a 19% decrease compared to previous year.
Compensation breakdown
| Bonus | $75,000 |
|---|---|
| Option Awards | $26,550 |
| Salary | $333,989 |
| Stock Awards | $39,926 |
| Other | $49,294 |
| Total | $524,759 |
van Dijk received $334K in salary, accounting for 64% of the total pay in 2023.
van Dijk also received $75K in bonus, $26.6K in option awards, $39.9K in stock awards and $49.3K in other compensation.
Rankings
In 2023, Marc van Dijk's compensation ranked 1,984th out of 3,006 executives tracked by ExecPay. In other words, van Dijk earned more than 34.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,984 out of 3,006 | 34th |
Division Manufacturing | 1,136 out of 1,650 | 31st |
Major group Chemicals And Allied Products | 703 out of 918 | 23rd |
Industry group Drugs | 686 out of 881 | 22nd |
Industry Biological Products, Except Diagnostic Substances | 178 out of 213 | 16th |
Source: SEC filing on April 29, 2024.
van Dijk's colleagues
We found two more compensation records of executives who worked with Marc van Dijk at MiNK Therapeutics in 2023.